Paragon owns and operates facilities designed and built specifically for small-batch production of proteins, monoclonal antibodies, recombinant vaccines, VLP’s and reagents for diagnostics at smaller scales and under cGMP regulations, suitable for Phase I /II clinical trials or research purposes.

• State-of-the-art process development laboratory.
• Segregated suites for microbial and mammalian/insect production.
• Separate suites for purification of all expression systems.
• Prevention of cross-contamination.
• Newly-validated, single-pass air, corridors, room classification
• Single-use disposables

Specific details describing our microbial fermentation suite, our cell culture production suite and our cell banking suites are available upon request.